ID   JVE241
AC   CVCL_EG27
SY   JVE-241
DR   cancercelllines; CVCL_EG27
DR   DSMZ; ACC-822
DR   DSMZCellDive; ACC-822
DR   GEO; GSM1655609
DR   GEO; GSM1655631
DR   Wikidata; Q54899183
RX   PubMed=26894854;
RX   PubMed=28931069;
CC   Doubling time: ~8-10 days (DSMZ=ACC-822).
CC   Microsatellite instability: Stable (MSS) (PubMed=26894854).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=26894854).
CC   Omics: DNA methylation analysis.
CC   Omics: SNP array analysis.
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Cecum; UBERON=UBERON_0001153.
ST   Source(s): DSMZ=ACC-822; PubMed=26894854
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D13S317: 10,11
ST   D16S539: 13
ST   D18S51: 16
ST   D19S433: 13,15
ST   D21S11: 29,30.2
ST   D2S1338: 17,20
ST   D3S1358: 15,16
ST   D5S818: 13,14
ST   D7S820: 9,10
ST   D8S1179: 14,15
ST   FGA: 21
ST   Penta D: 13
ST   Penta E: 5,12
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,18 (PubMed=26894854)
ST   vWA: 18 (DSMZ=ACC-822)
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
RX   PubMed=26894854; DOI=10.18632/oncotarget.7391; PMCID=PMC4924731;
RA   Boot A., van Eendenburg J.D.H., Crobach S., Ruano D., Speetjens F.,
RA   Calame J., Oosting J., Morreau H., van Wezel T.;
RT   "Characterization of novel low passage primary and metastatic
RT   colorectal cancer cell lines.";
RL   Oncotarget 7:14499-14509(2016).
//
RX   PubMed=28931069; DOI=10.1371/journal.pone.0184900; PMCID=PMC5607170;
RA   Boot A., Oosting J., van Eendenburg J.D.H., Kuppen P.J.K., Morreau H.,
RA   van Wezel T.;
RT   "Methylation associated transcriptional repression of ELOVL5 in novel
RT   colorectal cancer cell lines.";
RL   PLoS ONE 12:E0184900-E0184900(2017).
//